European Court of Auditors says it will investigate whether EU attempts to tackle antibiotic resistance provide value for money, on same day that health and food agencies say the problem is getting worse

Outcome-based pricing of cancer drugs could provide savings for payers and patients, but generating enough data on benefits remains a big challenge

Changes to the UK’s trading arrangements after it exits the EU will push up prices, cutting the amount of fresh produce people buy, a new study finds

Commission R&D funding for neglected diseases rose by 50 per cent in 2017. The UK and US remain the biggest funders - and UK spending increased by 89 per cent, says Australian charity

A leading geneticist recounts the story of one rogue scientist, and the damage he caused. ‘He should be stopped from doing anything like this again,’ says Robin Lovell-Badge

Time from patent to patient has increased by more than a year, Institute of Cancer Research finds in new study